Format
Items per page
Sort by

Send to:

Choose Destination

Results: 12

1.

Risk of radiation-related salivary gland carcinomas among survivors of Hodgkin lymphoma: a population-based analysis.

Boukheris H, Ron E, Dores GM, Stovall M, Smith SA, Curtis RE.

Cancer. 2008 Dec 1;113(11):3153-9. doi: 10.1002/cncr.23918.

PMID:
18823043
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Second cancers in survivors of hodgkin lymphoma: risks and recommendations.

Leahy Y.

Clin J Oncol Nurs. 2008 Jun;12(3):437-42. doi: 10.1188/08.CJON.437-442. Review.

PMID:
18515242
[PubMed - indexed for MEDLINE]
3.

[Long-term complications following treatment of testicular cancer and Hodgkin lymphoma].

van den Belt-Dusebout AW, Aleman BM, Gietema JA, de Wit R, van 't Veer MB, Lugtenburg PJ, Krol AD, van Leeuwen FE.

Ned Tijdschr Geneeskd. 2010;154(45):A2229. Review. Dutch.

PMID:
21118593
[PubMed - indexed for MEDLINE]
4.

Increased risk of second lung cancer in Hodgkin's lymphoma survivors: a meta-analysis.

Ibrahim EM, Kazkaz GA, Abouelkhair KM, Al-Mansour MM, Al-Fayea TM, Al-Foheidi M, Bayer AM, Elmasri OA.

Lung. 2013 Feb;191(1):117-34. doi: 10.1007/s00408-012-9418-4. Epub 2012 Oct 6. Review.

PMID:
23053567
[PubMed - indexed for MEDLINE]
5.

Screening Hodgkin lymphoma survivors for radiotherapy induced cardiovascular disease.

van Leeuwen-Segarceanu EM, Bos WJ, Dorresteijn LD, Rensing BJ, der Heyden JA, Vogels OJ, Biesma DH.

Cancer Treat Rev. 2011 Aug;37(5):391-403. doi: 10.1016/j.ctrv.2010.12.004. Epub 2011 Feb 18. Review.

PMID:
21333452
[PubMed - indexed for MEDLINE]
6.

Second malignant neoplasms and cardiovascular disease following radiotherapy.

Travis LB, Ng AK, Allan JM, Pui CH, Kennedy AR, Xu XG, Purdy JA, Applegate K, Yahalom J, Constine LS, Gilbert ES, Boice JD Jr.

J Natl Cancer Inst. 2012 Mar 7;104(5):357-70. doi: 10.1093/jnci/djr533. Epub 2012 Feb 6. Review.

PMID:
22312134
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Long-term complications of lymphoma and its treatment.

Ng AK, LaCasce A, Travis LB.

J Clin Oncol. 2011 May 10;29(14):1885-92. doi: 10.1200/JCO.2010.32.8427. Epub 2011 Apr 11. Review.

PMID:
21483015
[PubMed - indexed for MEDLINE]
8.

Appropriate surveillance for late complications in patients in remission from Hodgkin lymphoma.

Darrington DL, Vose JM.

Curr Hematol Malig Rep. 2012 Sep;7(3):200-7. doi: 10.1007/s11899-012-0128-z. Review.

PMID:
22743837
[PubMed - indexed for MEDLINE]
9.

Second malignant neoplasms: assessment and strategies for risk reduction.

Wood ME, Vogel V, Ng A, Foxhall L, Goodwin P, Travis LB.

J Clin Oncol. 2012 Oct 20;30(30):3734-45. doi: 10.1200/JCO.2012.41.8681. Epub 2012 Sep 24. Review.

PMID:
23008293
[PubMed - indexed for MEDLINE]
10.

Second malignant neoplasms and cardiovascular disease following radiotherapy.

Travis LB, Ng AK, Allan JM, Pui CH, Kennedy AR, Xu XG, Purdy JA, Applegate K, Yahalom J, Constine LS, Gilbert ES, Boice JD Jr.

Health Phys. 2014 Feb;106(2):229-46. doi: 10.1097/HP.0000000000000013. Review.

PMID:
24378498
[PubMed - indexed for MEDLINE]
11.

Current survivorship recommendations for patients with Hodgkin lymphoma: focus on late effects.

Ng AK.

Blood. 2014 Nov 27;124(23):3373-3379. Review.

PMID:
25428219
[PubMed - as supplied by publisher]
12.

Risks and diagnosis of coronary artery disease in Hodgkin lymphoma survivors.

Kupeli S.

World J Cardiol. 2014 Jul 26;6(7):555-61. doi: 10.4330/wjc.v6.i7.555. Review.

PMID:
25068016
[PubMed]
Free PMC Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk